Notes
Swedish Krona
Reference
Kiadaliri AA, et al. Cost-Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden. Diabetes Therapy 5: 591-607, No. 2, Jan 2014. Available from: URL: http://dx.doi.org/10.1007/s13300-014-0080-0
Rights and permissions
About this article
Cite this article
GLP-1 agonists cost effective for T2DM in Sweden. PharmacoEcon Outcomes News 720, 16 (2015). https://doi.org/10.1007/s40274-015-1855-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-1855-x